ARCHIVES

Industry Groups Lobby for Lower Standards for FDA Approval

This article is from The Cancer Letter archive.

Vol. 37 No. 43 | November 18, 2011

Download PDF Visit The Full Archive

Related Articles

Obey Insists NCI Pressured IARC Into Softening Report On Benzene Risk

August 20, 1982

UPCI Recruits Shin To Lead Head & Neck Cancer Program.

April 27, 2001

In Brief: Congress Recesses With No More Action On Waxman Bill; BCTF to Look at New Diagnosis, Detection

August 12, 1983

Kennedy, Waxman Disagree On Authorization Issue; Legislation For NIH, NCI This Congress Threatened

September 26, 1980

In Brief: Outstanding Investigator Awards Draw 150 Letters Of Intent; Applications Due July 15

June 15, 1984

NCI to hold 5 percent of division budgets in reserve for “strategic priorities.” Competing RPG budgets to be cut 18 percent on average.

February 13, 2004